COVID-19: FDA Revises Cardiovascular Warnings Concerning
COVID-19: The Food and Drug Administration of the United States has authorized updated labeling for two mRNA COVID-19 vaccines (Comirnaty; Pfizer and Spikevax; Moderna) that highlight the potential risk of myocarditis and pericarditis. Both vaccines have consistently included warnings on their labels regarding the possible risks associated with this side effect, emphasizing that the risk…